MindMed Archives

Psychedelics News

MindMed

Industry

28 Jul 2026

FDA’s New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.

For years, the psychedelic medicine industry has operated in largely uncharted regulatory territory. Companies developing psilocybin, LSD, MDMA, and next-generation psychedelic-inspired compounds have often found themselves navigating a clinical landscape...

By Madison Roberts

Events, Industry

13 Jul 2026

The Psychedelic Sector Has Grown Up. Wall Street Just Hasn’t Fully Realized It Yet

The sector experienced an early wave of enthusiasm fueled by bold promises, lofty valuations, and the belief that psychedelic medicine would quickly transform mental healthcare. Reality, however, proved more complicated....

By Madison Roberts

Science

14 Dec 2023

MindMed Announces Positive Results from Phase 2b Anxiety Trial

Big news as the trial met its primary endpoint, with 50% clinical remission rate at Week 4....

By Microdose NewsDesk

Industry

12 Sep 2023

MindMed Completes Dosing of Phase 2b Trial

MindMed has completed dosing of its main Phase 2b clinical trial. The study — investigating LSD for Generalized Anxiety Disorder (GAD) — has dosed 198 participants across 20 clinical sites....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Finance

4 Aug 2023

MindMed Reports Second Quarter 2023 Financial Results and Highlights

MindMed released its Q3 financial results. Highlights include enrolment in Phase 2b LSD trial, top-line results by end-of-year, and $116 million in cash....

By Microdose NewsDesk

Breaking News, Industry

22 Jun 2023

MindMed Survives Takeover Attempt: Shareholders Reject FCM Board Candidates

MindMed shareholders have voted to elect all 6 of the company’s proposed board members — rejecting the candidates from activist investors....

By Jason Najum

Science

6 Jun 2023

Candyflipping: New MindMed-Owned Study Looks at Combining MDMA and LSD

The new study, published this week in Nature, investigated whether MDMA can be used to optimize some of the effects of LSD, by adding some of the more positive mood...

By Jason Najum

Breaking News

25 May 2023

MindMed Publishes Report by FDA Experts: Is FCM’s Takeover Attempt Over?

A group of activist investors are trying to take control of MindMed’s board of directors. Today, MindMed has pushed back, potentially dealing a final blow to this increasingly suspect attempted...

By Jason Najum

Don’t Miss

22 May 2023

News You Might Have Missed: May 22nd 2023

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed....

By Microdose NewsDesk

Follow us on social

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result